title: Presurgical hyper-volaemic haemodilution for saving blood transfusion?
authors.forename: J
authors.initials: J
authors.lastname: Gille
authors.forename: V
authors.initials: V
authors.lastname: Winter
authors.forename: A
authors.initials: A
authors.lastname: Sablotzki
authors.forename: B
authors.initials: B
authors.lastname: Wiedemann
authors.forename: A
authors.initials: A
authors.lastname: Richter
authors.forename: R
authors.initials: R
authors.lastname: Serfas
mesh_terms: D001777:Blood Coagulation / Q000187:drug effects; D016063:Blood Loss, Surgical / Q000517:prevention & control; D001803:Blood Transfusion / Q000191:economics / Q000706:statistics & numerical data*; D002496:Central Venous Pressure / Q000187:drug effects; D015653:Cystectomy; D006438:Hemodilution / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D008297:Male; D010952:Plasma Substitutes / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D011300:Preoperative Care / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D011446:Prospective Studies; D011467:Prostate / Q000601:surgery; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000601:surgery*; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000601:surgery*
chemical_list: C485123:HES 130-0.4; D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes